REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults
Sponsor: Massachusetts General Hospital
Trial Details
| Condition | Type 2 Diabetes (Adult Onset), Medication Adherence |
| Intervention | REACH-Es; ETAU |
| Phase | NA |
| Status | Completed |
| Participants | 70 |
| Est. Completion | 27 May 2026 |
| Last Updated | 22 June 2026 |
Primary Outcome
Feasibility (recruitment rate); Feasibility (response rate to 2-way text messages); Feasibility (retention rate); Acceptability; Usability; Diabetes Medication adherence; IMB barrier sum score
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Type 2 diabetes mellitus * Have current or prior (since 2018) HbA1c ≥8.0% * Take at least one diabetes medication * Receive care at MGH- affiliated primary care practices (≥2 visits in the past 3 years) * ≥18 yrs * Identify as Latino and/or Hispanic * Speak and read in Spanish as preferred language * Willing and able to provide informed consent * Access to a mobile telephone with text messaging capability * Suboptimal diabetes medication adherence, assessed using the first 2 items in the Adherence to Refill and Medication Scale (ARMS-d) questionnaire combined: "How frequently do you forget or decide to not take your diabetes medications?" Participants who answer sometimes, almost always, and/or always will be considered eligible for the study. Exclusion Criteria: * Auditory limitations and/or inability to communicate orally * Inability to receive, read, or send a text message (assessed by a trained research assistant)
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service